Kura Oncology, Inc. · NASDAQ:KURA

Doyle Thomas James sold 4,607 Kura Oncology, Inc. shares (Form 4)

Traded Sep 28, 2026 · Filed Sep 29, 2026

On Sep 28, 2026, Doyle Thomas James (SVP, Finance & Accounting) sold 4,607 Kura Oncology, Inc. shares at US$10.50 for US$48,374, leaving 142,428 shares. Filed Sep 29, 2026 (Form 4).

Sold
4,607 shares
Price
US$10.50
Value
US$48,374
Holding after
142,428 shares
Trading plan
No
Role
SVP, Finance & Accounting

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 28, 2026Common StockSale4,607US$10.50142,428Direct

Source

View original at SEC

Related